Type I IFN signaling suppresses splenic T helper 1 (Th1) responses during blood-stage Plasmodium berghei ANKA (PbA) infection in mice, and is crucial for mediating tissue accumulation of parasites and fatal cerebral symptoms via mechanisms that remain to be fully characterized. Interferon regulatory factor 7 (IRF7) is considered to be a master regulator of type I IFN responses. Here, we assessed IRF7 for its roles during lethal PbA infection and nonlethal Plasmodium chabaudi chabaudi AS (PcAS) infection as two distinct models of blood-stage malaria. We found that IRF7 was not essential for tissue accumulation of parasites, cerebral symptoms, or brain pathology. Using timed administration of anti-IFNAR1 mAb, we show that late IFNAR1 signaling promotes fatal disease via IRF7-independent mechanisms. Despite this, IRF7 significantly impaired early splenic Th1 responses and limited control of parasitemia during PbA infection. Finally, IRF7 also suppressed antiparasitic immunity and Th1 responses during nonlethal PcAS infection. Together, our data support a model in which IRF7 suppresses antiparasitic immunity in the spleen, while IFNAR1-mediated, but IRF7-independent, signaling contributes to pathology in the brain during experimental blood-stage malaria.Keywords: Cytokines r Immune regulation r Interferons r Malaria r T helper cells Additional supporting information may be found in the online version of this article at the publisher's web-site Correspondence: Dr. Ashraful Haque e-mail: ashraful.haque@qimrbergofer.edu.au * These authors contributed equally to this work.C 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.eji-journal.eu Eur. J. Immunol. 2015. 45: 130-141 Immunity to infection 131
IntroductionType I IFNs are a family of closely related cytokines, widely known for their potent antiviral properties [1][2][3]. Recently, type I IFN, particularly IFN-β, has been used in the clinic to ameliorate the symptoms of multiple sclerosis, possibly via suppressive effects on T helper 1 (Th1) cells, although its precise mechanism of action remains unclear [4,5]. Type I IFN signaling occurs almost exclusively via the heterodimeric receptor, IFNAR1/2, which is widely expressed on hematopoietic and nonhematopoietic cells, although recent data also reveal IFNAR2-independent type I IFN signaling processes [6]. Most immune cells are capable of producing type I IFNs, including plasmacytoid dendritic cells (pDCs), which produce large amounts of these cytokines rapidly. Interferon regulatory factor 7 (IRF7) is a crucial transcription factor for driving type I IFN responses in mouse fibroblasts, pDCs, and conventional DCs (cDCs) in vitro, with concomitant severe defects in CD8 + T-cell priming and viral control in vivo [7]. Furthermore, IFN-α production by splenic pDCs and cDCs in vitro was completely dependent on IRF7, and independent of the closely related transcription factor, IRF3 [7]. Thus, IRF7 is often essential for driving type I IFN production, and IFNAR1-mediated signaling events. Consequently, IFNAR1-and IRF7 def...